Remberger M - Search Results

1

Allergic reactions and other rare side-effects of liposomal amphotericin.

Ringdén O, Andström E, Remberger M, Svahn BM, Tollemar J. Ringdén O, et al. Among authors: remberger m. Lancet. 1994 Oct 22;344(8930):1156-7. doi: 10.1016/s0140-6736(94)90663-7. Lancet. 1994. PMID: 7934512 No abstract available.

2

Safety of liposomal amphotericin B (AmBisome) in 187 transplant recipients treated with cyclosporin.

Ringdén O, Andström E, Remberger M, Svahn BM, Tollemar J. Ringdén O, et al. Among authors: remberger m. Bone Marrow Transplant. 1994;14 Suppl 5:S10-4. Bone Marrow Transplant. 1994. PMID: 7703925

3

No increase in cyclosporin neurotoxicity in transplant recipients treated with liposomal amphotericin B.

Ringdén O, Andström EE, Remberger M, Svahn BM, Tollemar J. Ringdén O, et al. Among authors: remberger m. Infection. 1996 May-Jun;24(3):269. doi: 10.1007/BF01781112. Infection. 1996. PMID: 8811371 No abstract available.

4

Safety and efficacy of liposomal amphotericin B in allogeneic bone marrow transplant recipients.

Andström EE, Ringdén O, Remberger M, Svahn BM, Tollemar J. Andström EE, et al. Among authors: remberger m. Mycoses. 1996 May-Jun;39(5-6):185-93. doi: 10.1111/j.1439-0507.1996.tb00123.x. Mycoses. 1996. PMID: 8909028

5

Prophylaxis and therapy using liposomal amphotericin B (AmBisome) for invasive fungal infections in children undergoing organ or allogeneic bone-marrow transplantation.

Ringdén O, Andström EE, Remberger M, Dahllöf G, Svahn BM, Tollemar J. Ringdén O, et al. Among authors: remberger m. Pediatr Transplant. 1997 Nov;1(2):124-9. Pediatr Transplant. 1997. PMID: 10084772

6

Survival after bone-marrow transplantation.

Remberger M, Ringdén O. Remberger M, et al. Lancet. 2002 Mar 9;359(9309):888. doi: 10.1016/S0140-6736(02)07926-6. Lancet. 2002. PMID: 11897308 No abstract available.

7

Individualized prophylaxis against graft-versus-host disease in leukemic marrow transplant recipients.

Aschan J, Ringdén O, Andström E, Ljungman P, Lönnqvist B, Remberger M. Aschan J, et al. Among authors: remberger m. Bone Marrow Transplant. 1994 Jul;14(1):79-87. Bone Marrow Transplant. 1994. PMID: 7951124 Clinical Trial.

8

Increased levels of soluble interleukin-2 receptor in veno-occlusive disease of the liver after allogenic bone marrow transplantation.

Remberger M, Ringdén O. Remberger M, et al. Transplantation. 1995 Dec 15;60(11):1293-9. Transplantation. 1995. PMID: 8525524

9

Cytokines in veno-occlusive disease of the liver after bone marrow transplantation.

Remberger M, Ringdén O. Remberger M, et al. Transplant Proc. 1995 Dec;27(6):3533-4. Transplant Proc. 1995. PMID: 8540087 No abstract available.

10

Serum levels of cytokines after bone marrow transplantation: increased IL-8 levels during severe veno-occlusive disease of the liver.

Remberger M, Ringdén O. Remberger M, et al. Eur J Haematol. 1997 Oct;59(4):254-62. doi: 10.1111/j.1600-0609.1997.tb00985.x. Eur J Haematol. 1997. PMID: 9338624

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters